BL
Insider
BIOS Fund II, LP
DirectorBIOS Fund II, LP (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in ACTU. Across 1 priced purchase filing, the average 21-session return was +5.5% from execution and +15.1% from disclosure (delay-adjusted; derived). The largest single filing was $500K of ACTU (71,428 sh × $7.00, as filed), executed Jun 27 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+5.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+15.1%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$500K
shares × price, as filed
Last traded
Jun 27 2025
Filed Jun 30 2025
Volume by month
Buys $500K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
ACTU
ACTU
ACTU · 1 buy · 0 sells
1 filing
Recent filings
ACTUPURCHASE
ACTUATE THERAPEUTICS, INC.
View filing →
$500K71,428 sh × $7.00
Exec Jun 27 2025
Filed Jun 30 2025 · 5:30 PM ET